• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases.

作者信息

Mezger J, Calavrezos A, Drings P, Gatzemeier U, Kaukel E, Konietzko N, Koschel G, Lamerz R, von Pawel J, Römer W

出版信息

Lung. 1994;172(3):183-4. doi: 10.1007/BF00175946.

DOI:10.1007/BF00175946
PMID:8201832
Abstract
摘要

相似文献

1
Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases.
Lung. 1994;172(3):183-4. doi: 10.1007/BF00175946.
2
Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.CYFRA 21-1肿瘤标志物和癌胚抗原在间皮瘤所致胸腔积液中的诊断价值
Chest. 2001 Apr;119(4):1138-42. doi: 10.1378/chest.119.4.1138.
3
Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma.肺腺癌和恶性间皮瘤所致胸腔积液中的肺表面活性物质蛋白-A和癌胚抗原
Eur Respir J. 1995 Mar;8(3):403-6. doi: 10.1183/09031936.95.08030403.
4
[Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].[酶免疫分析法联合检测胸腔积液和血清中癌胚抗原（CEA）的诊断价值。敏感性、特异性及与肿瘤类型的关系]
Wien Klin Wochenschr. 1986 Sep 12;98(17):564-73.
5
Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.癌胚抗原在恶性间皮瘤鉴别诊断中的诊断意义
J Thorac Cardiovasc Surg. 1990 Dec;100(6):860-6.
6
Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma.透明质酸在胸腔积液中对胸腔积液鉴别诊断的效用：恶性间皮瘤的似然比
Jpn J Clin Oncol. 1997 Oct;27(5):293-7. doi: 10.1093/jjco/27.5.293.
7
Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels.通过同时定量癌胚抗原（CEA）和神经元特异性烯醇化酶（NSE）的胸腔积液水平来改善肺癌患者胸腔积液病因的诊断。
Eur J Cancer. 1993;29A(13):1806-9. doi: 10.1016/0959-8049(93)90525-k.
8
Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.胸腔积液中透明质酸浓度作为恶性间皮瘤的诊断辅助手段。
Chest. 1988 Nov;94(5):1037-9. doi: 10.1378/chest.94.5.1037.
9
Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies.肿瘤标志物在间皮瘤和继发性胸膜恶性肿瘤鉴别诊断中的应用。
Clin Biochem. 2000 Jul;33(5):405-10. doi: 10.1016/s0009-9120(00)00157-0.
10
[Carcinoembryonic antigen in serum and pleural fluid to distinguish between bronchial carcinoma and pleural mesothelioma].
Dtsch Med Wochenschr. 1991 Feb 8;116(6):207-11. doi: 10.1055/s-2008-1063601.

引用本文的文献

1
Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.肿瘤标志物在胸腔积液中对肺癌相关恶性胸腔积液的辅助诊断价值。
Respir Res. 2020 Oct 29;21(1):284. doi: 10.1186/s12931-020-01557-z.
2
Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion.胸水与血清中癌胚抗原比值对恶性胸腔积液的诊断价值
Ther Adv Med Oncol. 2019 May 22;11:1758835919850341. doi: 10.1177/1758835919850341. eCollection 2019.
3
Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma.

本文引用的文献

1
Carcinoembryonic antigen in pleural effusions. Diagnostic value in malignant mesothelioma.胸腔积液中的癌胚抗原。在恶性间皮瘤中的诊断价值。
Cancer. 1984 Mar 1;53(5):1194-7. doi: 10.1002/1097-0142(19840301)53:5<1194::aid-cncr2820530528>3.0.co;2-n.
2
Detection of malignant pleural effusions by tumor marker evaluation.通过肿瘤标志物评估检测恶性胸腔积液。
Eur J Cancer Clin Oncol. 1988 Jun;24(6):1005-11. doi: 10.1016/0277-5379(88)90150-2.
3
Malignant mesothelioma of the pleura.胸膜恶性间皮瘤
积液中的可溶性间皮素：诊断恶性间皮瘤的有用工具。
Thorax. 2007 Jul;62(7):569-76. doi: 10.1136/thx.2006.068114. Epub 2007 Mar 13.
4
Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients.肿瘤标志物对鉴别伊朗患者恶性和良性胸腔积液的诊断价值。
Pathol Oncol Res. 2005;11(4):236-41. doi: 10.1007/BF02893857. Epub 2005 Dec 31.
5
Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.评估胸腔积液中的七种肿瘤标志物以诊断恶性胸腔积液。
Br J Cancer. 1999 Nov;81(6):1059-65. doi: 10.1038/sj.bjc.6690807.
Mayo Clin Proc. 1988 Dec;63(12):1234-44. doi: 10.1016/s0025-6196(12)65411-1.
4
Tumour associated antigens in diagnosis of serous effusions.肿瘤相关抗原在浆液性积液诊断中的应用
J Clin Pathol. 1988 Jun;41(6):633-43. doi: 10.1136/jcp.41.6.633.
5
Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.癌胚抗原在恶性间皮瘤鉴别诊断中的诊断意义
J Thorac Cardiovasc Surg. 1990 Dec;100(6):860-6.
6
Diagnosis of diffuse malignant mesothelioma: experience of a US/Canadian Mesothelioma Panel.弥漫性恶性间皮瘤的诊断：美国/加拿大间皮瘤专家组的经验
Mod Pathol. 1991 May;4(3):342-53.
7
[Carcinoembryonic antigen in serum and pleural fluid to distinguish between bronchial carcinoma and pleural mesothelioma].
Dtsch Med Wochenschr. 1991 Feb 8;116(6):207-11. doi: 10.1055/s-2008-1063601.
8
New strategies are needed in diffuse malignant mesothelioma.弥漫性恶性间皮瘤需要新的治疗策略。
Cancer. 1992 Dec 15;70(12):2969-79. doi: 10.1002/1097-0142(19921215)70:12<2969::aid-cncr2820701239>3.0.co;2-a.